查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1530036

体内注射器市场规模、份额和趋势分析报告：2024-2030 年按技术、应用、最终用途、地区和细分市场进行的预测

On-body Injectors Market Size, Share & Trends Analysis Report By Technology (Spring-based, Motor Driven), By Application (Oncology, Diabetes), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10个工作天内

价格

体载注射器市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球体贴注射器市场规模预计将达到127亿美元，2024年至2030年复合年增长率为14.9%。

体内注射器更易于使用、疼痛更少，并且允许在较长时间内给药而无需频繁去医院，从而提高了患者的用药依从性。这些优点使得体内注射器越来越受欢迎。此外，亚太地区等医疗基础设施发达且先进医疗设备的采用不断增加的地区在预测期内为市场成长提供了巨大的机会。

对针刺的日益关注以及需要透过消除与针头插入、药物製备、针头覆盖和处置相关的风险来提高患者和医疗保健专业人员的安全是预计癌症等慢性病患病率进一步增加的一些因素；推动预测期内的市场成长。

根据世界卫生组织国际癌症研究机构 (IARC) 的数据，到 2022 年，约有 2,000 万人将被诊断出罹患癌症，约 970 万人将死于癌症。有些癌症和其他慢性疾病的治疗需要长期频繁注射药物。与传统的医院就诊或自行注射相比，体内注射器为患者接受这些药物提供了更方便且潜在破坏性更小的替代方案。

体载注射器市场报告亮点

  • 从技术上来看，弹簧式在2023年占据最大的销售份额，为40.89%，其稳定的压力和速度保证了精确的计量。
  • 从技术角度来看，由于对剂量的更好控制、最大限度地减少用药错误的风险以及最大限度地提高治疗效果，旋转泵预计在预测期内将以 15.1% 的复合年增长率快速增长。
  • 从应用来看，由于第2型糖尿病盛行率较高，需要频繁给药，糖尿病领域在2023年占据了最大的销售份额。
  • 从应用来看，由于多发性硬化症、类风湿性关节炎和发炎性肠道疾病（IBD）等慢性自体自体免疫疾病的盛行率不断上升，预计自体免疫疾病领域将以最快的复合年成长率增长。
  • 根据最终用途，由于人们越来越偏好自行给药来治疗糖尿病、自体免疫疾病和癌症等慢性疾病，因此居家照护领域在 2023 年占据了最大的收益占有率。
  • 2023年，北美地区占33.17%。这是由于主要市场参与者的存在、居家照护的增加以及先进的体内注射器的使用增加。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章 车用注射器市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 体载注射器市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章 人体注射器市场：依技术估算与趋势分析

  • 细分仪表板
  • 体用注射器市场：技术差异分析
  • 体上註射器市场：技术展望
  • 2018-2030年市场规模、预测及趋势分析
  • 弹簧底座
  • 马达驱动
  • 旋转泵
  • 扩充电池
  • 其他的

第五章 体内注射器市场：依应用估算与趋势分析

  • 细分仪表板
  • 体用注射器市场：依应用进行变化分析
  • 体上註射器市场：按应用分類的前景
  • 2018-2030年市场规模、预测及趋势分析
  • 肿瘤学
  • 糖尿病
  • 心血管疾病
  • 自体免疫疾病
  • 其他的

第六章 体内注射器市场：依最终用途分类的估计与趋势分析

  • 细分仪表板
  • 体用注射器市场：最终用途的变化分析
  • 体上註射器市场：依最终用途分類的前景
  • 2018-2030年市场规模、预测及趋势分析
  • 医院/诊所
  • 居家照护环境
  • 其他的

第七章 体内注射器市场：区域估计与趋势分析

  • 区域仪表板
  • 体载注射器市场：区域差异分析
  • 体用注射器市场：按技术、应用和最终用途进行区域估计和趋势分析
  • 2018-2030年市场规模、预测及趋势分析
  • 北美洲
    • 2018-2030年北美人体注射器市场估计与预测
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030 年欧洲人体注射器市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030 年亚太地区体上註射器市场估计与预测
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 2018-2030 年拉丁美洲人体注射器市场估计与预测
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 2018-2030 年中东和非洲体内注射器市场估计和预测
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 市场参与企业分类
  • 主要企业简介
    • West Pharmaceutical Services, Inc.
    • BD
    • Stevanato Group
    • Enable Injections
    • Nemera
    • Debiotech SA
    • AbbVie, Inc.
    • Coherus BioSciences, Inc.
    • Gerresheimer AG
    • E3D Elcam Drug Delivery Devices
Product Code: GVR-4-68040-395-4

On-body Injectors Market Growth & Trends:

The global on-body injectors market size is expected to reach USD 12.7 billion by 2030, registering a CAGR of 14.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. The on-body injectors increase patient adherence to medication by offering easy-to-use, less pain and enabling extended drug administration without frequent hospital visits. These advantages of on-body injectors are significantly increasing their popularity. Moreover, regions such as Asia Pacific, with developing healthcare infrastructure and rising adoption of advanced medical devices, offer huge opportunities for market growth over the forecast period.

The increasing concerns over needle stick injuries and the need to increase the safety for both patients and healthcare professionals by eliminating risks associated with needle insertion, drug preparation, and covering & disposing of needles, coupled with the increasing prevalence of chronic diseases such as cancer are some of the factors expected to drive the market growth over the forecast period.

According to the WHO agency International Agency for Research on Cancer (IARC), around 20 million people were diagnosed with cancer, and around 9.7 million mortalities occurred due to cancer in 2022. Several cancers and other chronic disease treatments require frequent injections of medications over extended periods. On-body injectors offer a convenient and potentially less disruptive alternative for patients to receive these medications compared to traditional hospital visits or self-administered injections, which can significantly increase their demand over the forecast period.

On-body Injectors Market Report Highlights:

  • Based on the technology, the spring-based segment accounted for the largest revenue share of 40.89% in 2023 owing to their consistent pressure and speed, which ensures precise dosing
  • Based on technology, the rotary pump segment is expected to grow at the fastest CAGR of 15.1% during the forecast period owing to the high control offered by them in dispensing medications, minimizing the risk of dosing errors and maximizing therapeutic efficacy
  • Based on the application, the diabetes segment accounted for the largest revenue share in 2023 due to the high prevalence of type 2 diabetes, which requires frequent administration
  • Based on the application, the autoimmune diseases segment is expected to grow at the fastest CAGR owing to the rising prevalence of chronic autoimmune conditions such as multiple sclerosis, rheumatoid arthritis, and Inflammatory Bowel Diseases (IBD)
  • Based on the end use, the homecare segment accounted for the largest revenue share in 2023 owing to the growing preference for self-administration of medications for managing chronic conditions such as diabetes, autoimmune disorders, and cancer in homecare settings
  • In 2023, North America dominated with a share of 33.17%, driven by the presence of key market players, an increasing shift toward home care, and better access to advanced on-body injectors

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.1. Segment Definitions
    • 1.1.1. Technology
    • 1.1.2. Application
    • 1.1.3. End Use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecasts timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. Application outlook
    • 2.2.3. End Use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. On-body Injectors Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of chronic diseases
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Patient preference and compliance
      • 3.2.1.4. Increasing focus on home healthcare
      • 3.2.1.5. Increasing concerns about needlestick injuries
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost compared to alternatives
  • 3.3. On-body Injectors Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. On-body Injectors Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. On-body Injectors Market: Technology Movement Analysis
  • 4.3. On-body Injectors Market by Technology Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Spring-based
    • 4.5.1. Spring-based Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Motor-driven
    • 4.6.1. Motor-driven Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Rotary Pump
    • 4.7.1. Rotary Pump Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Expanding Battery
    • 4.8.1. Expanding Battery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. Other
    • 4.9.1. Other Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. On-body Injectors Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. On-body Injectors Market: Application Movement Analysis
  • 5.3. On-body Injectors Market by Application Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Oncology
    • 5.5.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Diabetes
    • 5.6.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Cardiovascular Disease
    • 5.7.1. Cardiovascular Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Autoimmune Disease
    • 5.8.1. Autoimmune Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. On-body Injectors Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. On-body Injectors Market: End Use Movement Analysis
  • 6.3. On-body Injectors Market by End Use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Hospitals & Clinics
    • 6.5.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Home Care Settings
    • 6.6.1. Home Care Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. On-body Injectors Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Regional On-body Injectors Market movement analysis
  • 7.3. On-body Injectors Market: Regional Estimates & Trend Analysis by Technology, Application & End Use
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. North America
    • 7.5.1. North America On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. U.S. On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Canada On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement scenario
      • 7.5.4.5. Mexico On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. Europe On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. UK
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. UK On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Germany
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. Germany On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. France
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. France On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Italy
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement scenario
      • 7.6.5.5. Italy On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Spain
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement scenario
      • 7.6.6.5. Spain On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Denmark
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement scenario
      • 7.6.7.5. Denmark On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.8. Sweden
      • 7.6.8.1. Key Country Dynamics
      • 7.6.8.2. Competitive Scenario
      • 7.6.8.3. Regulatory Framework
      • 7.6.8.4. Reimbursement scenario
      • 7.6.8.5. Sweden On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.9. Norway
      • 7.6.9.1. Key Country Dynamics
      • 7.6.9.2. Competitive Scenario
      • 7.6.9.3. Regulatory Framework
      • 7.6.9.4. Reimbursement scenario
      • 7.6.9.5. Norway On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Asia Pacific On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Japan
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Japan On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. China
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. China On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.4. India
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. Reimbursement scenario
      • 7.7.4.5. India On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Reimbursement scenario
      • 7.7.5.5. South Korea On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.6. Australia
      • 7.7.6.1. Key Country Dynamics
      • 7.7.6.2. Competitive Scenario
      • 7.7.6.3. Regulatory Framework
      • 7.7.6.4. Reimbursement scenario
      • 7.7.6.5. Australia On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.7. Thailand
      • 7.7.7.1. Key Country Dynamics
      • 7.7.7.2. Competitive Scenario
      • 7.7.7.3. Regulatory Framework
      • 7.7.7.4. Reimbursement scenario
      • 7.7.7.5. Thailand On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Latin America On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. Brazil
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. Brazil On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. Argentina On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9. Middle East & Africa
    • 7.9.1. Middle East & Africa On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.2. South Africa
      • 7.9.2.1. Key Country Dynamics
      • 7.9.2.2. Competitive Scenario
      • 7.9.2.3. Regulatory Framework
      • 7.9.2.4. Reimbursement scenario
      • 7.9.2.5. South Africa On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.3. Saudi Arabia
      • 7.9.3.1. Key Country Dynamics
      • 7.9.3.2. Competitive Scenario
      • 7.9.3.3. Regulatory Framework
      • 7.9.3.4. Reimbursement scenario
      • 7.9.3.5. Saudi Arabia On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.4. UAE
      • 7.9.4.1. Key Country Dynamics
      • 7.9.4.2. Competitive Scenario
      • 7.9.4.3. Regulatory Framework
      • 7.9.4.4. Reimbursement scenario
      • 7.9.4.5. UAE On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.5. Kuwait
      • 7.9.5.1. Key Country Dynamics
      • 7.9.5.2. Competitive Scenario
      • 7.9.5.3. Regulatory Framework
      • 7.9.5.4. Reimbursement scenario
      • 7.9.5.5. Kuwait On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. West Pharmaceutical Services, Inc.
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. BD
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Stevanato Group
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Enable Injections
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Nemera
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Debiotech SA
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. AbbVie, Inc.
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Coherus BioSciences, Inc.
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Gerresheimer AG
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. E3D Elcam Drug Delivery Devices
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 4 Global on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 6 North America on-body injectors market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 8 North America on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 11 U.S. on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 14 Canada on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 17 Mexico on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe on-body injectors market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 21 Europe on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 23 UK on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 24 UK on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 25 UK on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Germany on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Germany on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 28 Germany on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 30 France on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 31 France on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Italy on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 36 Spain on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Norway on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 39 Norway on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 40 Norway on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Sweden on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 42 Sweden on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Denmark on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 45 Denmark on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 46 Denmark on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific on-body injectors market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Japan on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 52 Japan on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 53 Japan on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 54 China on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 55 China on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 56 China on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 58 India on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 59 India on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Australia on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 61 Australia on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 62 Australia on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 63 South Korea on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 64 South Korea on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 65 South Korea on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Thailand on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 67 Thailand on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 68 Thailand on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America on-body injectors market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 71 Latin America on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 72 Latin America on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 74 Brazil on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 77 Argentina on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa on-body injectors market, by country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 83 South Africa on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 84 South Africa on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Africa on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 89 UAE on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 90 UAE on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 91 UAE on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 93 Kuwait on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 94 Kuwait on-body injectors market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 On-body injectors market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 On-body injectors market, technology outlook key takeaways (USD Million)
  • Fig. 12 On-body injectors market: Technology movement analysis (USD Million), 2023 & 2030
  • Fig. 13 Spring-based market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Motor-driven market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Rotary pump market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Expanding battery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Other market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 On-body injectors market, application outlook key takeaways (USD Million)
  • Fig. 19 On-body injectors market: Application movement analysis (USD Million), 2023 & 2030
  • Fig. 20 Oncology market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Diabetes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Cardiovascular disease market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Autoimmune disease market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 On-body injectors market, end use outlook key takeaways (USD Million)
  • Fig. 26 On-body injectors market: End use movement analysis (USD Million), 2023 & 2030
  • Fig. 27 Hospitals & clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Home care settings market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 On-body injectors market: Regional key takeaways (USD Million)
  • Fig. 31 On-body injectors market: Regional outlook, 2023 & 2030, USD Million
  • Fig. 32 North America on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Canada on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Mexico on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Europe on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 UK on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Germany on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 France on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Spain on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Italy on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Sweden on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Norway on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Denmark on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 China on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Japan on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 India on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 South Korea on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Australia on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Thailand on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Argentina on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Middle East and Africa on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 South Africa on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Saudi Arabia on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 UAE on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Kuwait on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 List of key emerging company's/technology disruptors/innovators